Morgan Stanley Upgrades Cemex to Overweight, Maintains Price Target to $14

Morgan Stanley analyst Nikolaj Lippmann has upgraded Cemex (NYSE: CX) from Equal-Weight to Overweight. The price target for the stock remains unchanged at $14.